Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Immunome (IMNM) Accumulated Depreciation & Amortization (2023 - 2025)

Immunome (IMNM) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $4.7 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Accumulated Depreciation & Amortization rose 21.52% year-over-year to $4.7 million, compared with a TTM value of $4.7 million through Dec 2024, up 21.52%, and an annual FY2024 reading of $4.7 million, up 21.52% over the prior year.
  • Accumulated Depreciation & Amortization was $4.7 million for Q4 2024 at Immunome, up from $3.9 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $4.7 million in Q4 2024 and bottomed at $3.9 million in Q4 2023.